« Return to News | CROs/Service Providers

Clearstone Central Laboratories Winds Down Cardiac Services Business

Friday, June 11, 2010 09:00 AM

Clearstone Central Laboratories, a provider of central laboratory services for clinical trials, intends to sell or wind down over time its centralized cardiac services business in order to focus on its core laboratory business.

“Clearstone has set out to be a market leader, and in doing so we have had to make some strategic decisions to position the business for service excellence and growth. This action allows us to focus all of our efforts on further developing our core laboratory business” said Clearstone CEO Lewis Cameron. “We will continue to make significant investments in our facilities, people, technology and processes.”

The company also announced a restructuring due in part to this strategic repositioning. As such, a number of positions will be affected at the company’s Baillet lab operations in Paris, France.

 “It will take some months to work through the redundancy plan with our Baillet Works Council in accordance with French labor laws,” added Cameron. “We will be taking every step possible to support affected staff and continue providing clients with the highest level of service during the transition period. In the meantime, it is very much business as usual in our core laboratory operations, and we look to the future with great optimism as we continue to focus on service delivery and growth in emerging markets.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.